| Additional file 1 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 12 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 11 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 10 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 13 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 14 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 15 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 16 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 2 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 3 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 4 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 5 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 6 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 7 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 8 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 9 of Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate | 2022 |
| Additional file 1 of Probable human origin of the SARS-CoV-2 polybasic furin cleavage motif | 2023 |
| Analysis of the variance and regression coefficients for the predicted model for the response variables in Citrus sinensis pulp. | 2019 |
| ANOLEA results for the two templates (2CN5 and 2J90) and the hIKK-2 homology model. | 2011 |
| Baseline characteristics of participants completing 1-year intervention.A | 2014 |
| Bile acids and risk of adverse cardiovascular events and all-cause mortality in patients with acute coronary syndrome | 2023 |
| Codes for DPP-IV structures currently available at PDB. | 2012 |
| Data for: Combined effects of GBH residues and phosphate fertilizers on endophytic microbiota and plant performance of garden strawberry | 2023 |
| Dataset from Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice | 2022 |
| Effects of 1-Year Intervention with a Mediterranean Diet on Plasma Fatty Acid Composition and Metabolic Syndrome in a Population at High Cardiovascular Risk | 2014 |
| Face-centered settings for the independent variables and experimental results for hesperidin and the total phenolic content (TPC) in Citrus sinensis pulp. | 2019 |
| Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the IKK-2 Kinase Domain, Virtual Screening and Activity Assays | 2011 |
| Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays | 2012 |
| Optimization of a polyphenol extraction method for sweet orange pulp (Citrus sinensis L.) to identify phenolic compounds consumed from sweet oranges | 2019 |
| Overall optimal values for the extraction parameters for hesperidin and the total phenolic content in Citrus sinensis pulp. | 2019 |
| Partial correlation coefficients between 1-year changes in plasma fatty acids and 1-year changes in metabolic risk factors (n = 424) and between food groups and plasma fatty acids.A | 2014 |
| Plasma fatty acid levels at baseline and 1-year changes according to the intervention groups.A | 2014 |
| Plasma fatty acid levels at baseline and 1-year changes according to the 1-year change in the MetS status.A | 2014 |
| Replication data for: A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets | 2023 |
| Replication Data for Intestinal Morphometric Changes Induced by a Western-Style Diet in Wistar Rats and GSPE Counter-Regulatory Effect | 2024 |
| RT-qPCR dCT values of genes analyzed in colon, small intestine, liver and colon organoids | 2022 |
| Site contribution to the energy-optimized pharmacophores obtained from PDB complexes in bold from Table 1. | 2012 |
| Supplementary Data | 2021 |
| The phenolic contents from Navelina sweet orange pulps from the northern (NO) and southern (SO) hemispheres by HPLC-ESI-MS/MS expressed as mg/kg dw ± SD (n = 3, each). | 2019 |
Repositori URV